Posts By NoelW

ProPharma /PWR are seeking your assistance please. The brand change from Orion to Douglas has not gone as smooth as would have been expected. There has been a lot of confusion as to what is available, what is listed in the Pharmaceutical Schedule and so on. Most demand has been met, but not without some challenges. We are seeking your…

PHARMAC notification today:- Famotidine Ranitidine is a type of medicine called an H2 antagonist. PHARMAC has secured supply of an alternative H2 antagonist as a result of the previously notified pharmacy level recall of all batches of Ranitidine 150 mg and 300 mg tablets. Our clinical advice is that some patients may be able to be transitioned to a proton pump inhibitor…

Click here to read the notification of 11 December 2019 from Mylan. Please take special note of the information contained and note the following additional information. Acetec Tablets are being listed from 1 January 2020 and will be dual listed along with Enalapril Ethics Tablets for 5 months, being the transition period. Sole Supply for Acetec Tablets will commence 1…

Click here to read the AFT notification relating to the above mentioned product. (Both article and Facsimile Reply Form) You must immediately complete and fax the acknowledgement form provided regardless of whether you have stock or not. This is a requirement under your current ICPSA. NOTE: ProPharma /PWR will not be processing credit returns. Credits should be returned to AFT…

Click here to read an important notification relating to a supply constraint on the above mentioned product. Epipen Auto-Injector 300ug  Pharmacode 223972 is unaffected ProPharma / PWR have again been proactive and have set in place an allocation of 1 per customer per week for Epipen Jr. We accept one size does not fit all, but in these instances where…

As advised via PHARMAC proposal of 22 October 2019 and the notification of PHARMAC decision of 5 December 2019 there is to be a change in the listing and future sole supply of bortezomib injections. New listing from 1 March 2020 Bortezomib – Dr Reddy’s Inj 3.5 mg vial                                                                            Pharmacode TBA                  Schedule price $105.00 Bortezomib – Baxter Inj…

As advised via PHARMAC Tender Results of 31 May 2019 there is to be a change in the listing and future sole supply of Compound Electrolytes. (Refer to Mind Time article 5 July 2019) New listing from 1 November 2019 Electral Powder for Oral Solution 50 sachet pack                                                           Pharmacode 2576937                    Schedule price $9.77 Incumbent brand Enerlyte Powder for…

The following notification from Boucher & Muir Pty Ltd relating to the resupply of the above mentioned product. Please be advised that the registered brand Parnate 10mg tabs 50’s is now back in supply. If you have existing backorders with Healthcare Logistics, your orders will be processed shortly. If you have not yet placed an order, please do so as…

As advised in the Pharmaceutical Schedule Update 13 September 2019 this product is being discontinued and will be delisted 1 May 2020. Discontinuation is effective immediately as all supplies have been sold. The planned replacement was to be:- Isoptin SR Tab 120 mg 100                                 Pharmacode 2571897        Schedule Price $36.02 However due to issues in obtaining stock the following has…

As advised via PHARMAC Tender Results of 29 November 2019 there is to be a change in the listing and future sole supply of Olopatadine eye drops. New listing from 1 May 2020 Olopatadine Eye Drops 0.1% 5 ml OP                                                                                 Pharmacode TBA                  Schedule price $2.20 Incumbent brand Patanol Eye drops 0.1% 5 ml OP                                                                                          Pharmacode 2099365        …

Close